Skip to main content

Advertisement

Figure 3 | BMC Research Notes

Figure 3

From: Alpha-santalol, a chemopreventive agent against skin cancer, causes G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells

Figure 3

Effects of α-santalol on the distribution of UACC-62 cells in the different phases of the cell cycle. UACC-62 Cells were treated with α-santalol (0 μM-75 μM) for 6 h (A and B), 12 h (C and D) and 24 h (E and F). Data were summarized and presented as the mean ± SD of three observations. *, P < 0.05 indicates statistical significance in α-sanatlol treated groups as compared to the control in UACC-62 cells.

Back to article page